• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients.

作者信息

Bertaggia-Calderara D, Kröll D, Gerschheimer C, Nicolas N, Nett P, Stirnimann G, Alberio L

机构信息

Division of Hematology and Central Hematology Laboratory, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

出版信息

Int J Lab Hematol. 2018 Feb;40(1):e11-e14. doi: 10.1111/ijlh.12767. Epub 2017 Dec 14.

DOI:10.1111/ijlh.12767
PMID:29239121
Abstract
摘要

相似文献

1
Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients.利伐沙班对体内凝血酶生成的影响。一项针对肥胖患者的研究。
Int J Lab Hematol. 2018 Feb;40(1):e11-e14. doi: 10.1111/ijlh.12767. Epub 2017 Dec 14.
2
Influences of Obesity and Bariatric Surgery on the Clinical and Pharmacologic Profile of Rivaroxaban.肥胖和减重手术对利伐沙班的临床和药理学特征的影响。
Am J Med. 2017 Sep;130(9):1024-1032. doi: 10.1016/j.amjmed.2017.05.011. Epub 2017 Jun 8.
3
[Evaluation of oral anticoagulation with rivaroxaban, in patients with new onset non valvular atrial fibrillation].利伐沙班用于新诊断非瓣膜性心房颤动患者口服抗凝治疗的评估
Rev Med Chil. 2016 Sep;144(9):1103-1111. doi: 10.4067/S0034-98872016000900002.
4
[CHANGE OF ANTICOAGULANT EFFECT OF RIVAROXABAN DURING A DAY].
Vestn Khir Im I I Grek. 2015;174(4):77-9.
5
Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban.利伐沙班治疗纯合子先天性蛋白S缺乏症患者的凝血酶生成及其他凝血参数
Int J Hematol. 2016 Feb;103(2):165-72. doi: 10.1007/s12185-015-1898-6. Epub 2015 Nov 19.
6
Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis.瑞伐沙班剂量调整采用血栓生成在严重先天性蛋白 C 缺乏和华法林诱导的皮肤坏死。
Blood Adv. 2018 Jan 23;2(2):142-145. doi: 10.1182/bloodadvances.2017012047.
7
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.利伐沙班对血小板活化及血小板-凝血途径相互作用的影响：体外和体内研究
J Cardiovasc Pharmacol Ther. 2015 Nov;20(6):554-62. doi: 10.1177/1074248415578172. Epub 2015 Apr 6.
8
Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats.利伐沙班对大鼠凝血活性的给药时间依赖性效应。
J Pharmacol Sci. 2017 Aug;134(4):234-238. doi: 10.1016/j.jphs.2017.08.001. Epub 2017 Aug 12.
9
Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin/protease-activated receptor-2 system.利伐沙班通过阻断凝血酶/蛋白酶激活受体-2系统，抑制晚期糖基化终产物暴露的肾小管细胞中的氧化和炎症反应。
Thromb Res. 2015 Apr;135(4):770-3. doi: 10.1016/j.thromres.2015.01.023. Epub 2015 Jan 23.
10
Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement.阿哌沙班和利伐沙班预防血栓形成剂量与全髋关节置换术相关的凝血及凝血酶生成的影响
J Thromb Thrombolysis. 2017 May;43(4):562-569. doi: 10.1007/s11239-017-1492-2.

引用本文的文献

1
Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy.纤维蛋白成像和血栓成像（血栓动力学-4D）在80岁及以上接受直接口服抗凝剂治疗的老年房颤患者直接口服抗凝剂评估中的应用
Res Pract Thromb Haemost. 2025 Jul 15;9(5):102969. doi: 10.1016/j.rpth.2025.102969. eCollection 2025 Jul.
2
Direct oral anticoagulants in cirrhosis: Rationale and current evidence.直接口服抗凝剂在肝硬化中的应用：理论依据与当前证据。
JHEP Rep. 2024 May 9;6(8):101116. doi: 10.1016/j.jhepr.2024.101116. eCollection 2024 Aug.
3
Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial.
利伐沙班用于减肥手术后患者术后血栓预防的疗效和安全性：一项随机临床试验。
JAMA Netw Open. 2023 May 1;6(5):e2315241. doi: 10.1001/jamanetworkopen.2023.15241.
4
Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases.用于出血和血栓性疾病个性化治疗的凝血酶生成检测。
Front Cardiovasc Med. 2022 Nov 10;9:1033416. doi: 10.3389/fcvm.2022.1033416. eCollection 2022.
5
Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients.评估 DOAC 在老年人群中的应用（Adage 研究）：NVAF 超高龄患者中利伐沙班/阿哌沙班的浓度和凝血酶生成谱。
Thromb Haemost. 2023 Apr;123(4):402-414. doi: 10.1055/a-1981-1763. Epub 2022 Nov 17.
6
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.用于利伐沙班、阿哌沙班和依度沙班测定的自动凝血酶生成测定法。
Front Cardiovasc Med. 2021 Sep 9;8:717939. doi: 10.3389/fcvm.2021.717939. eCollection 2021.
7
Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants.服用直接口服抗凝剂12小时后凝血酶生成的抑制作用。
Res Pract Thromb Haemost. 2020 Apr 23;4(4):610-618. doi: 10.1002/rth2.12332. eCollection 2020 May.
8
Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report.一名患有杂合子因子V莱顿突变的女性使用复方口服避孕药时的凝血酶生成：病例报告
Res Pract Thromb Haemost. 2020 Mar 2;4(3):429-432. doi: 10.1002/rth2.12318. eCollection 2020 Mar.